Anaphylactic and non-anaphylactic murine IgG1 differ in their ability to bind to mast cells: Relevance of proper glycosylation of the molecule

Immunobiology

Volumn 207, Issue 3, 2003, Pages 169-177

  Faquim Mauro, Eliana L ^a   Jacysyn, Jacqueline F ^a   Macedo, Mahasti S ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BETA N ACETYLHEXOSAMINIDASE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1; NITROGEN;

ANAPHYLAXIS; ANIMAL CELL; ANTIBODY PRODUCTION; ANTIBODY STRUCTURE; ANTIGEN ANTIBODY REACTION; ANTIGEN SPECIFICITY; ARTICLE; BINDING AFFINITY; CELL ACTIVATION; CELL LINE; CELL SURFACE; CONTROLLED STUDY; ENZYME RELEASE; HYBRIDOMA; IN VIVO STUDY; MAST CELL; MOUSE; NONHUMAN; PASSIVE SKIN ANAPHYLAXIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN GLYCOSYLATION;

EID: 0037852140     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1078/0171-2985-00231     Document Type: Article

References (26)

1. Coffman RL, Lebman DA and Rothman P. 1993. Mechanism and regulation of immunoglobulin isotype switching. Adv. Immunol. 54: 229-270.
2. Faquim-Mauro EL and Macedo MS. 2000. Induction of IL-4-dependent, anaphylactic-type and IL-4-independent, non-anaphylactic-type IgG1 antibodies is modulated by adjuvants. Int. Immunol. 12: 1733-1740.
3. Faquim-Mauro EL, Coffman RL, Abrahamsohn IA and Macedo MS. 1999. Cutting Edge: Mouse IgG1 antibodies comprise two functionally distinct types that are differentially regulated by IL-4 and IL-12. J. Immunol. 163: 3572-3576.
4. Galli SJ. 1993. New concepts about the mast cell. N. Engl. J. Med. 328: 257-265.
5. Hazenbos WL, Gessner JE, Hofhuis FM, Kuipers H, Meyer D, Heijnen IA, Schmidt RE, Sandor M, Capel PJ, Daeron M, van der Winkel JG and Verbeck JS. 1996. Impaired IgG-dependent anaphylaxis and Arthus reaction in Fc gamma RIII (CD16) deficient mice. Immunity 5: 181-188.
6. Hazenbos WL, Heijnen IA, Meyer D, Hofhuis FM, Renardel de Lavalette CR, Schmidt RE, Capel PJ, van der Winkel JG, Gessner JE, van der Berg TK and Verbeck JS. 1998. Murine IgG1 complexes trigger immune effector functions predominantly via Fc gamma RIII (CD16). J. Immunol. 161: 3026-3032.
7. Ishizaka K. 1989. Basic mechanisms of IgE-mediated hypersensitivity. Curr. Opin. Immunol. 1: 625-629.
8. Ishizaka T and Ishizaka K. 1984. Activation of mast cells for mediator release through IgE receptors. Prog. Allergy 34: 188-235.
9. Jefferis R, Lund J and Pound JD. 1998. IgG-Fc-mediated effector functions: molecular definition of interaction sites for effector ligands and the role of glycosylation. Immunol. Rev. 163: 59-76.
10. Leatherbarrow RJ, Rademacher TW, Dwek RA, Woof JM, Clark A, Burton DR, Richardson N and Feinstein A. 1985. Effector functions of a monoclonal aglycosylated mouse IgG2a: binding and activation of complement component C1 and interaction with human monocyte Fc receptor. Mol. Immunol. 22: 407-415.
11. Lowry OH, Rosebrough NJ, Farr AL, and Randall RJ. 1951. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193: 265-275.
12. Lund J, Takahashi N, Nakagawa H, Goodall M, Bentley T, Hindley SA, Tyler R and Jefferis R. 1993. Control of IgG/Fc glycosylation: a comparison of oligosaccharides from chimeric human/mouse and mouse subclass immunoglobulin Gs. Mol. Immunol. 30: 741-748.
13. Lund J, Takahashi N, Pound JD, Goodall M, and Jefferis R. 1996. Multiple interactions of IgG with its core oligosaccharide can modulate recognition by complement and human Fcγ receptor I and influence the synthesis of its oligosaccharide chains. J. Immunol. 157: 4963-4969.
14. Mimura Y, Church S, Ghirlando R, Ashton PR, Dong S, Goodall M, Lund J and Jefferis R. 2000. The influence of glycosylation on the thermal stability and effector function expression of human IgG1-Fc: properties of a series of truncated glycoforms. Mol. Immunol. 37: 697-706.
15. Miyajima I, Dombrowicz D, Martin TR, Ravetch JV, Kinet JP and Galli SJ. 1997. Systemic anaphylaxis in the mouse can be mediated largely through IgG1 and Fc gammaRIII. Assessment of the cardiopulmonary changes, mast cell degranulation, and death associated with active or IgE- or IgG1-dependent passive anaphylaxis. J. Clin. Invest. 99: 901-914.
16. Nissim A, Jouvin MH and Eshhar Z. 1991. Mapping of the high affinity Fc epsilon receptor binding site to the third constant region domain of IgE. EMBO J. 10: 101-107.
17. Ortega E, Schneider H and Pecht I. 1991. Possible interactions between the Fc epsilon receptor and a novel mast cell function-associated antigen. Int. Immunol. 3: 333-342.
18. Ovary Z. 1958. Passive cutaneous anaphylaxis in the mouse. J. Immunol. 81: 355.
19. Patel TP, Parekh RB, Moellering BJ and Prior CP. 1992. Different culture methods lead to differences in glycosylation of a murine IgG monoclonal antibody. Biochem. J. 285: 839-845.
20. Ravetch JV. 1997. Fc receptors. Curr. Opin. Immunol. 9: 121-125.
21. Ravetch JV and Kinet JP. 1991. Fc receptors. Annu. Rev. Immunol. 9: 457-492.
22. Serafin WE and Austen KF. 1987. Mediators of immediate hypersensitivity reactions. N. Engl. J. Med. 317: 30-34.
23. Sondermann P, Huber R, Oosthuizen V and Jacob U. 2000. The 3.2-A crystal structure of the human IgG1 Fc fragment-Fc gammaRIII complex. Nature 406: 267-273.
24. Weinshank RL, Luster AD and Ravetch JV. 1988. Function and regulation of a murine macrophage-specific IgG Fc receptor, Fc gamma R-alpha. J. Exp. Med. 167: 1909-1925.
25. Wright A and Morrison SL. 1997. Effect of glycosylation on antibody function: implications for genetic engineering. Trends Biotechnol. 15: 26.
26. Zar JH. 1984. Biostatistical Analysis. Prentice Hall, New York, N.Y.